Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis

  1. Giri, S.
  2. Grimshaw, A.
  3. Bal, S.
  4. Godby, K.
  5. Kharel, P.
  6. Djulbegovic, B.
  7. Dimopoulos, M.A.
  8. Facon, T.
  9. Usmani, S.Z.
  10. Mateos, M.-V.
  11. Costa, L.J.
Revue:
JAMA Oncology

ISSN: 2374-2445 2374-2437

Année de publication: 2020

Volumen: 6

Número: 11

Pages: 1759-1765

Type: Révision

DOI: 10.1001/JAMAONCOL.2020.4338 GOOGLE SCHOLAR